679685, Abrahams, Shameemah, et al
While the medication itself is effective, outcomes are highly dependent on how dosing is managed over time
one common approach began at 0.5 mg once weekly , with incremental increases at approximately four-weekly intervals up to target maintenance doses of 4 mg, 8 mg, or 12 mg once weekly
This leads to an inflammatory response as the trapped enzymes start digesting the pancreas itself
This approach allows adaptation to the compound while minimizing adverse effects during adjustment periods
A head-to-head review of clinical studies determined that among available GLP-1 RAs, there were A1C reductions from 0.78% to 1.9%